
4D Molecular Therapeutics Inc (FDMT)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -19.699 | -63.537 | -32.717 | -22.223 | -34.938 | -33.515 |
Return on Equity (%) | 69.243 | 98.066 | -61.819 | -24.785 | -39.057 | -37.405 |
Return on Invested Capital (%) | -27.744 | -7709.036 | -62.221 | -28.159 | -46.212 | -43.282 |
Operating Margin (%) | -67.594 | -705.783 | -416.493 | -395.371 | -3435.411 | -486.595 |
Net Profit Margin (%) | -67.594 | -705.783 | -416.493 | -395.371 | -3435.411 | -486.595 |
Book Value Per Share | 14.708 | -14.09 | 9.609 | 9.902 | 7.09 | 7.2 |
Earnings Per Share | -1.863 | -9.52 | -2.125 | -2.213 | -3.295 | -2.359 |
Cash Per Share | 17.901 | 9.587 | 10.371 | 4.748 | 1.605 | 5.827 |
Working Capital Per Share | 16.78 | 7.637 | 9.966 | 7.446 | 6.276 | 6.494 |
Operating Profit Per Share | 2.757 | 1.349 | 0.51 | 0.56 | 0.096 | 0.485 |
EBIT Per Share | -1.863 | -9.52 | -2.125 | -2.213 | -3.295 | -2.359 |
EBITDA Per Share | -1.863 | -9.52 | -2.125 | -2.213 | -3.295 | -2.359 |
Free Cash Flow Per Share | -1.918 | -9.096 | -2.141 | -1.978 | -3.015 | -2.392 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 5,13M | 5,18M | 26,68M | 32,23M | 32,63M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 32,63M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -9624.832 | N/A | N/A | N/A | -115717.857 | N/A | N/A |
Net Profit Margin (%) | N/A | -9624.832 | N/A | N/A | N/A | -115717.857 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 180,06M |
Ratio cours/bénéfice | -1,88 |
Ratio prix/ventes | 9,17 |
Ratio prix/liquidités | 0,76 |
Ratio prix/valeur comptable | 0,62 |
Rendement de dividende | - |
Actions en circulation | 46,23M |
Volume moyen (1 semaine) | 858,47k |
Volume moyen (1 mois) | 772,04k |
Variation sur 52 semaines | -86,13% |
Plus haut sur 52 semaines | 36,25 |
Plus bas sur 52 semaines | 3,84 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales